Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Keyomarsi

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Oncogene|April 21, 2001
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53S S Bacus, A V Gudkov, M Lowe, et al.
Oncogene|August 18, 2015
PKCiota promotes ovarian tumor progression through deregulation of cyclin EA Nanos-Webb, T Bui, C Karakas, et al.
Molecular Biology of the Cell|April 1, 1995
Inhibition of cyclin-dependent kinases by p21J W Harper, S J Elledge, K Keyomarsi, et al.
Oncogene|May 11, 2010
A novel interaction between HER2/neu and cyclin E in breast cancerE A Mittendorf, Y Liu, S L Tucker, et al.
Oncogene|June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cellsS S Bacus, Y Yarden, M Oren, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Oncogene|April 21, 2001
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53S S Bacus, A V Gudkov, M Lowe, et al.
Oncogene|August 18, 2015
PKCiota promotes ovarian tumor progression through deregulation of cyclin EA Nanos-Webb, T Bui, C Karakas, et al.
Molecular Biology of the Cell|April 1, 1995
Inhibition of cyclin-dependent kinases by p21J W Harper, S J Elledge, K Keyomarsi, et al.
Oncogene|May 11, 2010
A novel interaction between HER2/neu and cyclin E in breast cancerE A Mittendorf, Y Liu, S L Tucker, et al.
Oncogene|June 20, 1996
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cellsS S Bacus, Y Yarden, M Oren, et al.
Pageof 5